December 12, 2005
Phase 1 Clinical Data Demonstrates Gemin X Compound GX15-070 is Well-Tolerated and Generates Biological and Clinical Improvements in CLL
December 12, 2005
Results from Preclinical Studies of Gemin X’s GX15-070 Presented in Four Posters at American Society of Hematology Annual Meeting
Nov 28, 2005
Naviscan PET Systems, Inc. Announces Strategic Relocation to San Diego, California
Nov 28, 2005
Naviscan PET Systems, Inc. Completes $6.5 Million Series B Financing
November 23, 2005
Tomophase Corporation Closes $4.5 M Series A Financing Round
November 2, 2005
Endocyte Receives Notice of a U.S. Patent Allowance for a Targeted Immunotherapy Treatment
November 1, 2005
Founder Dr. Ken M. Kengatharan Joins Athenagen Inc. To Lead Pre-clinical R&D – Company Also Adds Senior Director of Chemistry
October 20, 2005
Athenagen Adds Dr. Henry Hsu as Chief Medical Officer
– Industry Veteran to Lead Clinical Programs
October 20, 2005:
ISTA Pharmaceuticals Announces Phase III Data ...
October 19 , 2005:
Dynavax Announces Third Quarter 2005 Financial ...
October 17, 2005
NovoStent Names G. Ray Martin, PhD, President &
CEO
September 19, 2005
Athenagen Raises $5.69 Million Series A Financing
August 17, 2005
NovoStent Completes Second Close Raising a Total
of $12.75 Million in New Financing
August 11, 2005
Alteer™ Corporation Announces Completion of $16.5 Million Funding...
July 21, 2005
Altor BioScience Awarded SBIR Grant for Manufacturing Therapeutic Antibodies in Transgenic Plants
July 19, 2005
Cylene Pharmaceuticals Initiates Phase I Clinical Trial for CX-3543, a First-in-Class Agent for Multiple Cancers
July 13, 2005
Richard Messmann join’s Endocyte’s executive management team
June 11, 2005
Iken Tissue Therapeutics Names CEO
May 25, 2005
Cylene Pharmaceuticals Raises $26.3 Million in Series B Financing
May 18, 2005
NovoStent Raises $9.65 Million in New Financing
April 28, 2005
Bayer Healthcare AG Spin-out, Actimis Pharmaceuticals, completes $6 million Series A Financing
April 27, 2005
Dynatherm Medical receives Medical Design Excellence Award by Medical Device & Diagnostic Industry Magazine
April 26, 2005
Purdue anchors Indy's newest technology park, 3 companies move in
April 2005
Thinking Big In Texas Nature
April 2005
New Apoptosis Drugs Face Critical Test Nature Biotechnology
March 30, 2005
Emory Researchers Awarded $1.6 Million to Study Common Type of Pituitary Tumor
February 7, 2005
Cylene Pharmaceuticals Moves Headquarters and R&D Operations to State-of-the-Art San Diego Facility
January 19, 2005
Altor BioScience Establishes Collaboration with Leading MGH Investigator to Develop TCR-based Agents to Detect and Treat HIV and HCV Infection